Uncertainty-aware MR-based CT synthesis for robust proton therapy planning of brain tumour.

Brain Tumours MR-based CT Synthesis Proton Therapy Robust Planning Uncertainty Estimation

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
15 Dec 2023
Historique:
received: 01 05 2023
revised: 06 12 2023
accepted: 08 12 2023
medline: 18 12 2023
pubmed: 18 12 2023
entrez: 17 12 2023
Statut: aheadofprint

Résumé

Deep learning techniques excel in MR-based CT synthesis, but missing uncertainty prediction limits its clinical use in proton therapy. We developed an uncertainty-aware framework and evaluated its efficiency in robust proton planning. A conditional generative-adversarial network was trained on 64 brain tumour patients with paired MR-CT images to generate synthetic CTs (sCT) from combined T1-T2 MRs of three orthogonal planes. A Bayesian neural network predicts Laplacian distributions for all voxels with parameters (μ, b). A robust proton plan was optimized using three sCTs of μ and μ±b. The dosimetric differences between the plan from sCT (sPlan) and the recalculated plan (rPlan) on planning CT (pCT) were quantified for each patient. The uncertainty-aware robust plan was compared to conventional robust (global ±3%) and non-robust plans. In 8-fold cross-validation, sCT-pCT image differences (Mean-Absolute-Error) were 80.84±9.84HU (body), 35.78±6.07HU (soft tissues) and 221.88±31.69HU (bones), with Dice scores of 90.33±2.43%, 95.13±0.80%, and 85.53±4.16%, respectively. The uncertainty distribution positively correlated with absolute prediction error (Correlation Coefficient: 0.62±0.01). The uncertainty-conditioned robust optimisation improved the rPlan-sPlan agreement, e.g., D95 absolute difference (CTV) was 1.10±1.24% compared to conventional (1.64±2.71%) and non-robust (2.08±2.96 %) optimisation. This trend was consistent across all target and organs-at-risk indexes. The enhanced framework incorporates 3D uncertainty prediction and generates high-quality sCTs from MR images. The framework also facilitates conditioned robust optimisation, bolstering proton plan robustness against network prediction errors. The innovative feature of uncertainty visualisation and robust analyses contribute to evaluating sCT clinical utility for individual patients.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Deep learning techniques excel in MR-based CT synthesis, but missing uncertainty prediction limits its clinical use in proton therapy. We developed an uncertainty-aware framework and evaluated its efficiency in robust proton planning.
MATERIALS AND METHODS METHODS
A conditional generative-adversarial network was trained on 64 brain tumour patients with paired MR-CT images to generate synthetic CTs (sCT) from combined T1-T2 MRs of three orthogonal planes. A Bayesian neural network predicts Laplacian distributions for all voxels with parameters (μ, b). A robust proton plan was optimized using three sCTs of μ and μ±b. The dosimetric differences between the plan from sCT (sPlan) and the recalculated plan (rPlan) on planning CT (pCT) were quantified for each patient. The uncertainty-aware robust plan was compared to conventional robust (global ±3%) and non-robust plans.
RESULTS RESULTS
In 8-fold cross-validation, sCT-pCT image differences (Mean-Absolute-Error) were 80.84±9.84HU (body), 35.78±6.07HU (soft tissues) and 221.88±31.69HU (bones), with Dice scores of 90.33±2.43%, 95.13±0.80%, and 85.53±4.16%, respectively. The uncertainty distribution positively correlated with absolute prediction error (Correlation Coefficient: 0.62±0.01). The uncertainty-conditioned robust optimisation improved the rPlan-sPlan agreement, e.g., D95 absolute difference (CTV) was 1.10±1.24% compared to conventional (1.64±2.71%) and non-robust (2.08±2.96 %) optimisation. This trend was consistent across all target and organs-at-risk indexes.
CONCLUSION CONCLUSIONS
The enhanced framework incorporates 3D uncertainty prediction and generates high-quality sCTs from MR images. The framework also facilitates conditioned robust optimisation, bolstering proton plan robustness against network prediction errors. The innovative feature of uncertainty visualisation and robust analyses contribute to evaluating sCT clinical utility for individual patients.

Identifiants

pubmed: 38104781
pii: S0167-8140(23)09363-5
doi: 10.1016/j.radonc.2023.110056
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110056

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Xia Li (X)

Center for Proton Therapy, Paul Scherrer Institut; Department of Computer Science, ETH Zurich.

Renato Bellotti (R)

Center for Proton Therapy, Paul Scherrer Institut; Department of Physics, ETH Zurich.

Gabriel Meier (G)

Center for Proton Therapy, Paul Scherrer Institut.

Barbara Bachtiary (B)

Center for Proton Therapy, Paul Scherrer Institut.

Damien Weber (D)

Center for Proton Therapy, Paul Scherrer Institut; Department of Radiation Oncology, University Hospital of Zurich; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern.

Antony Lomax (A)

Center for Proton Therapy, Paul Scherrer Institut; Department of Physics, ETH Zurich.

Joachim Buhmann (J)

Department of Computer Science, ETH Zurich.

Ye Zhang (Y)

Center for Proton Therapy, Paul Scherrer Institut. Electronic address: ye.zhang@psi.ch.

Classifications MeSH